Clinical Trials in Næstved, Region Sjælland
1 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC1,200 enrolled257 locationsNCT06312176
Recruiting
Not Applicable
Circulating Tumor DNA Guided Treatment Monitoring in Advanced Lung Cancer
Non-small Cell Lung Cancer Metastatic
Zealand University Hospital350 enrolled5 locationsNCT05889247
Recruiting
Not Applicable
Protons Vs. Photons for High-risk Prostate Cancer
Radiotherapy Side EffectProstate Cancer
University of Aarhus400 enrolled7 locationsNCT05350475